Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Good
|
|
New words:
AFR, American, Antibacterial, arm, attest, AU, bad, begun, biomedical, blood, breakeven, broader, Bruce, chair, chairman, chairperson, closer, COBRA, de, DECA, dedicated, division, entry, EPS, excise, exploring, Fairly, feasibility, flow, foregoing, Half, hierarchy, indefinitely, interval, lab, levofloxacin, load, lump, mde, meaningfully, memorialized, microbial, moist, nonconvertible, North, OIS, OP, optimal, OTM, Pakistan, paragraph, pen, population, postpone, preceding, propagation, proper, provision, put, regular, renegotiated, renegotiation, resignation, sensation, simultaneously, Slovakia, Society, sooner, Spray, statistically, summer, supervision, therapeutic, Thornton, thought, today, unvested, upward, usage, Vetericyn, viable, view, visit, Walco, world, Yen
Removed:
accredited, announce, asCidalcyn, asserting, assertion, attribute, automobile, Black, cancelled, charge, combined, contacting, controlsIn, coordinating, damage, declared, Demacyn, denominated, derecognition, derive, difficulty, discretionary, dismissal, disposition, distribute, documenting, eliminate, enrolling, exclusivity, expiration, extended, foreclosing, grew, healthy, implementation, imposing, increasing, incremental, inventory, irritation, Kono, leak, limitation, liquidated, marksMicrocyn, measurable, member, microbiological, MicrocynandDermacynin, Microcynapplication, modification, monitoring, month, multiplying, Naoshi, national, NOL, noted, obligated, pilot, plaintiff, planning, predicting, promptly, pronouncement, quarantined, question, referred, reflected, relation, reliably, replaced, restricted, revaluation, revise, suit, supported, taxable, theMicrocyn, theMicrocynmark, threshold, tissue, tradename, treating, twenty, ulcer, undertaken, underwriting, unqualified, usingMicrocynalong, utilization, utilized
Filing tables
Filing exhibits
Related press release
SNOA similar filings
Filing view
External links
Exhibit 32.2
STATEMENT OF CHIEF FINANCIAL OFFICER UNDER 18 U.S.C. § 1350
I, Robert Miller, the chief financial officer of Oculus Innovative Sciences, Inc. (the “Company”), certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code that, to the best of my knowledge,
(1) the Quarterly Report of the Company on Form 10-Q for the period ended June 30, 2008 (the “Report”), fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934, and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| By: | /s/ Robert Miller | |||
| Robert Miller | ||||
| Chief Financial Officer | ||||
Date: August 5, 2008